The fight for a life-changing drug: Getting Trikafta approve

The fight for a life-changing drug: Getting Trikafta approved in Alberta


“That’s where our journey with cystic fibrosis began,” said Chris Bushell, Zack’s father.
For Zack, being diagnosed with cystic fibrosis meant two decades of respiratory infections, hospital visits, and at one point, a lung capacity of 40 per cent. That was until the family discovered Trikafta.
“Zach was born in the U.S. and this new miracle drug has been available in the U.S. for nearly two years,” Chris told CTV News Edmonton. “We were able to get it for him, and within three weeks (of use) his lung function improved by 70 per cent.”
Cystic fibrosis is a genetic disease that affects protein development in human cells. It can affect the respiratory system, digestive and reproductive tract. Ultimately, it can make an impact on life expectancy and overall quality of life.

Related Keywords

Canada , Canadians , Canadian , Karin Campbell , Chris Bushell , Zack Bushell , Martha Mckinney , Alberta Health , Canadian Agency For Drugs , Health Canada , Technologies In Health , Twenty Year Old Zack Bushell , Canadian Agency , Stollery Children , கனடா , கனடியர்கள் , கனடியன் , கரின் கேம்ப்பெல் , மார்த்தா மகிநீ , ஆல்பர்ட்டா ஆரோக்கியம் , ஆரோக்கியம் கனடா , தொழில்நுட்பங்கள் இல் ஆரோக்கியம் ,

© 2025 Vimarsana